12:00 AM
May 26, 2014
 |  BC Week In Review  |  Clinical News  |  Regulatory

Access AccuTnl+3 troponin I assay regulatory update

The U.K.'s NICE issued draft guidance recommending the Elecsys Troponin T high-sensitive assay from Roche (SIX:ROG; OTCQX:RHHBY, Basel, Switzerland) and the Architect Stat High Sensitive Troponin-I assay from Abbott Laboratories (NYSE:ABT, Abbott Park, Ill.) for the early rule out of non-ST-segment elevation...

Read the full 228 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >